These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 15033641)
1. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. O'Brien KL; Santosham M Am J Epidemiol; 2004 Apr; 159(7):634-44. PubMed ID: 15033641 [TBL] [Abstract][Full Text] [Related]
2. Pneumococcal conjugate vaccine for young children. Selman S; Hayes D; Perin LA; Hayes WS Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663 [TBL] [Abstract][Full Text] [Related]
3. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). Nuorti JP; Whitney CG; MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868 [TBL] [Abstract][Full Text] [Related]
4. Possibility of application of new pneumococcal conjugate vaccines in children in Slovenia. Paragi M; Kolman J; Kraigher A; Cizman M; Gubina M; Ribic H; Vaccine; 2003 Dec; 21(32):4708-14. PubMed ID: 14585680 [TBL] [Abstract][Full Text] [Related]
5. A cross-sectional survey of the prevalence of Streptococcus pneumoniae nasopharyngeal carriage in Belgian infants attending day care centres. Malfroot A; Verhaegen J; Dubru JM; Van Kerschaver E; Leyman S Clin Microbiol Infect; 2004 Sep; 10(9):797-803. PubMed ID: 15355410 [TBL] [Abstract][Full Text] [Related]
7. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection. Darkes MJ; Plosker GL Paediatr Drugs; 2002; 4(9):609-30. PubMed ID: 12175274 [TBL] [Abstract][Full Text] [Related]
8. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541 [TBL] [Abstract][Full Text] [Related]
9. A conjugate vaccine for the prevention of pediatric pneumococcal disease. Murray D; Jackson C Mil Med; 2002 Aug; 167(8):671-7. PubMed ID: 12188240 [TBL] [Abstract][Full Text] [Related]
10. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections. Zangeneh TT; Baracco G; Al-Tawfiq JA Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases. Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505 [TBL] [Abstract][Full Text] [Related]
13. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956 [TBL] [Abstract][Full Text] [Related]
14. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
15. Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children. Esposito S; Principi N J Immunol Res; 2015; 2015():591580. PubMed ID: 26351648 [TBL] [Abstract][Full Text] [Related]
16. Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine. Gruber WC; Scott DA; Emini EA Ann N Y Acad Sci; 2012 Aug; 1263():15-26. PubMed ID: 22830997 [TBL] [Abstract][Full Text] [Related]
17. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Overturf GD Pediatrics; 2000 Aug; 106(2 Pt 1):367-76. PubMed ID: 10920170 [TBL] [Abstract][Full Text] [Related]